Emami accepts resignation of Company Secretary Ravi Varma effective August 31

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Emami Limited accepted the resignation of Company Secretary Ravi Varma
  • The change takes effect on August 31, 2026
  • Mr. Varma also steps down as the company's Nodal Officer
  • Disclosure filed under SEBI Listing Regulations Regulation 30
  • Mr. Varma cited professional growth as the reason for leaving
powered bylight_fuzz_icon
49535975

*this image is generated using AI for illustrative purposes only.

Emami Limited has accepted the resignation of Mr. Ravi Varma as Company Secretary and Compliance Officer, effective August 31, 2026. The company disclosed the change in a filing with stock exchanges on August 29, 2026.

Mr. Varma also ceases to act as the Nodal Officer of the company in compliance with Rule 7 (2A) of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Particulars Details
Reason for Change Resignation of Mr. Ravi Varma
Effective Date August 31, 2026
Previous Role Company Secretary and Compliance Officer

Resignation Details

In his resignation letter dated August 28, 2026, Mr. Varma stated he chose to explore new opportunities for professional growth outside the organisation. He confirmed there were no other reasons for his departure.

Harsh Vardhan Agarwal, Vice Chairman and Managing Director, signed the intimation letter to the exchanges.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-2.14%-6.87%-8.38%-17.99%-33.76%-36.40%

Who has been appointed as the interim or permanent successor to Mr. Ravi Varma as Company Secretary and Compliance Officer?

How might this leadership change in compliance roles impact Emami's regulatory reporting timelines and investor relations during the transition period?

Are there any pending regulatory audits or compliance issues at Emami that could be influenced by this change in the Nodal Officer?

Emami reappoints Harsha Vardhan Agarwal as MD for five years

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Shareholders reappointed Harsha Vardhan Agarwal as Vice-Chairman & Managing Director
  • The five-year term is effective from April 1, 2027
  • The resolution was passed at the 43rd AGM held on August 25, 2026
  • Other directors Aditya Vardhan Agarwal and Prashant Goenka were also reappointed
powered bylight_fuzz_icon
49228116

*this image is generated using AI for illustrative purposes only.

Emami Limited shareholders approved the reappointment of Harsha Vardhan Agarwal as Vice-Chairman and Managing Director for a five-year term effective April 1, 2027. The resolution was passed at the company’s 43rd Annual General Meeting held on August 25, 2026.

The new term begins upon the completion of his current tenure on March 31, 2027. Co-founder and Non-Executive Chairman R. S. Goenka presided over the meeting, which commenced at 4:00 pm and concluded at 6:25 pm. He confirmed the presence of a requisite quorum and noted that all directors were present except Smt. Avani Davda. Committee chairmen Anand Rathi and C. K. Dhanuka also attended.

Goenka informed members that the statutory and secretarial audit reports contained no qualifications or adverse remarks. He briefly outlined the company’s performance and thanked shareholders for their continued trust.

Resolutions Passed

Company Secretary Ravi Varma detailed the resolutions transacted during the AGM. Members voted on ordinary business items including the adoption of standalone and consolidated audited financial statements for the fiscal year ended March 31, 2026.

The board proposed the reappointment of three directors retiring by rotation:

  • Harsha Vardhan Agarwal
  • Aditya Vardhan Agarwal
  • Prashant Goenka

Special business items included ratifying the remuneration of Harsha Vardhan Agarwal and approving his reappointment to the role for five years. The meeting also ratified the remuneration for M/s. V. K. Jain & Co., the cost auditors for FY27.

Voting Results

Mr. Raj Kumar Banthia, Partner of M/s. MKB & Associates, Practicing Company Secretaries, was appointed to scrutinize the e-voting process. In terms of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, all resolutions set out in the Notice have been duly passed by the members with requisite majority.

The e-voting results and scrutinizer’s report were filed with stock exchanges on August 26, 2026. CEO - Finance, Strategy & Business Development N. H. Bhansali addressed queries from pre-registered members during the session.

Historical Stock Returns for Emami

1 Day5 Days1 Month6 Months1 Year5 Years
-2.14%-6.87%-8.38%-17.99%-33.76%-36.40%

How might Harsha Vardhan Agarwal's extended tenure influence Emami's strategic pivot towards personal care and healthcare segments over the next five years?

What impact could the reappointment of the Agarwal and Goenka family directors have on shareholder confidence regarding corporate governance and succession planning?

Given the clean statutory audit reports, what specific operational efficiencies or cost-control measures is Emami likely to prioritize in FY27 to maintain profitability?

More News on Emami

1 Year Returns:-33.76%